Fine-Tuning Antithymocyte Globulin Dosing and Harmonizing Clinical Trial Design

J Clin Oncol. 2018 Apr 10;36(11):1175-1176. doi: 10.1200/JCO.2017.77.1774. Epub 2018 Feb 7.

Authors

Jaap Jan Boelens¹, Rick Admiraal¹, Jurgen Kuball¹, Stefan Nierkens¹

Affiliation

¹ Jaap Jan Boelens, Rick Admiraal, Jurgen Kuball, and Stefan Nierkens, University Medical Centre Utrecht, Utrecht, the Netherlands.

PMID: 29412785
DOI: 10.1200/JCO.2017.77.1774

No abstract available

Publication types

Letter
Comment

MeSH terms

Antilymphocyte Serum*
Clinical Trials as Topic
Disease-Free Survival
Double-Blind Method
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents
Prospective Studies
T-Lymphocytes

Substances

Antilymphocyte Serum
Immunosuppressive Agents